https://auntresodamid.com/iJugHxINePLH1VY/96561

Health News

Solace garners M to expand health advocacy network

Solace garners $60M to expand health advocacy network

Solace, a healthcare navigation platform, announced it scored $60 million in Series B funding. Menlo Ventures led the round with participation from existing investors Inspired Capital, Torch Capital and Craft Ventures, and new investor SignalFire.  WHAT IT DOES Solace matches patients with advocates who help them navigate their healthcare journey, whether through navigating a new […]

Solace garners $60M to expand health advocacy network Read More »

knownwell joins LillyDirect to expand metabolic care

knownwell joins LillyDirect to expand metabolic care

Hybrid weight-inclusive primary and metabolic care provider knownwell announced it will be listed as a care provider on pharma giant Eli Lilly’s digital healthcare platform LillyDirect. knownwell touts itself as a hybrid weight-inclusive provider offering primary care and metabolic health services. The Boston-based company has brick-and-mortar locations in Texas, Chicago and Massachusetts. Lilly launched LillyDirect in

knownwell joins LillyDirect to expand metabolic care Read More »

Child Mind launches mental health journaling app for teens

Child Mind launches mental health journaling app for teens

The Child Mind Institute, a children’s mental health resource, has partnered with the California Department of Healthcare Services to launch Mirror, an intuitive mental health journaling app for teens. Free of charge, Mirror aims to enhance emotional processing and offer a supportive environment for self-reflection.  The Mirror app allows users to self-express and understand patterns

Child Mind launches mental health journaling app for teens Read More »

Digital twin company Unlearn partners with Trace Neuroscience

Digital twin company Unlearn partners with Trace Neuroscience

Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates genomic therapies for neurodegenerative diseases. Unlearn, founded in 2017, uses machine learning to create digital twins of clinical trial participants before being randomized in a controlled trial.  The digital twin

Digital twin company Unlearn partners with Trace Neuroscience Read More »

Tech-enabled Eargo, hearX merge to form new hearing aid company

Tech-enabled Eargo, hearX merge to form new hearing aid company

Eargo, which makes tech-enabled hearing aids, and hearX, maker of Lexie hearing aids, announced they have merged to form a new company, LXE Hearing. Eargo is a direct-to-consumer hearing aid company, while hearX markets a suite of digital, mobile technologies for hearing loss detection and diagnosis. The new company, LXE Hearing, received $100 million in

Tech-enabled Eargo, hearX merge to form new hearing aid company Read More »

Texas judge strikes down FDA rule on lab-developed tests regulation

Texas judge strikes down FDA rule on lab-developed tests regulation

A federal judge in Texas ruled that the FDA overstepped its authority when it issued its Final Rule: Medical Devices; Laboratory Developed Tests in May of last year, which said laboratory-developed tests (LDTs) should be regulated as medical devices. In a 450-page lawsuit filed by the American Clinical Laboratory Association (ACLA), molecular testing laboratory for

Texas judge strikes down FDA rule on lab-developed tests regulation Read More »

Isomorphic Labs secures 0M in funding for AI drug design

Isomorphic Labs secures $600M in funding for AI drug design

Drug design and development company Isomorphic Labs announced it raised $600 million dollars in its first external funding round. Thrive Capital led the round with participation from GV (Google Ventures) and existing investor Alphabet. WHAT IT DOES Isomorphic Labs, launched in 2021 with Google DeepMind, unveiled its newest joint AI offering AlphaFold 3, an AI

Isomorphic Labs secures $600M in funding for AI drug design Read More »

Don’t miss latest news!

Select list(s):

We don’t spam! Read our [link]privacy policy[/link] for more info.

🕶 Relax!

Put your feet up and let us do the hard work for you. Sign up to receive our latest news directly in your inbox.

Select Your Choice:

We’ll never send you spam or share your email address.
Find out more in our Privacy Policy.

Scroll to Top